Cytotoxic and pro-apoptotic activities of medicarpin from Canavalia maritima (Aubl.) via the suppression of NF-κB activation in HeLa cells

Abstract

Abstract:

Three known pterocarpin derivatives, (-)-medicarpin (PD1), (-)-2-hydroxy4,9-dimethoxypterocarpan (PD2), and 4-hydroxy-3-methoxy-8,9-methylene-dioxypterocarpan (PD3) were isolated from Canavalia maritima, for the first time. The cytotoxic and pro-apoptotic activities of (-)-medicarpin in cutured human tumor HeLa cells and its effect on NF-κB activation were investigated. We found that PD1 inhibited NF-κB activation by high content screening analysis, and PD1 exhibited cytotoxicity by SRB assay. In addition, we found that PD1 induced nuclear condensation and increased membrane permeability and mitochondrial transmembrane potential in HeLa cells in a dose and time dependent manner. In conclusion, our data suggested that (-)-medicarpin was capable of inhibiting tumor cell growth in vitro and inducing apoptosis, which might be via the suppression of NF-κB activation.

Key words: Medicarpin, Medicarpin, Canavalia maritime, Canavalia maritime, Anticancer, Anticancer, Apoptosis, Apoptosis, NF-κB, NF-κB, High content screening, High content screening

CLC Number:

R62.1

Supporting:

Min-Juan Xu, Xin-Ping Huang, Min Li^*, Wan Sun, Jing-Rong Cui, Wen-Han Lin . Cytotoxic and pro-apoptotic activities of medicarpin from Canavalia maritima
(Aubl.) via the suppression of NF-κB activation in HeLa cells [J]. .

References

[1] Chinese Virtual Herbarium, http://www.cvh.org.cn/zhiwuzhi/page/41/211a.PDF
[2] Sridhar, K.R.; Seena, S. Food Chem. 2006, 99, 267-288.
[3] Gadelha, C.; Moreno, F.; Santi-Gadelha, T.; Cajazeiras, J.; Matias da Rocha, B.; Assreuy, A.; Mota, M.; Vieira Pinto, N.; Meireles, A.; Borges, J.; Freitas, B.; Canduri, F.; Souza, E.; Delatorre, P.; Criddle, D.; Filgueira de Azevedo, W.; Cavada, B. J. Struct. Biol. 2005, 152, 185-194.
[4] Aggarwal, B.B.; Shishodia, S. Biochem. Pharmcol. 2006, 71, 1397-1421.
[5] Baud, V.; Karin, M. Nat. Rev. Drug Discov. 2009, 8, 33-40.
[6] Militão, G.; Dantas, I.; Pessoa, C.; Falcão, M.; Silveira, E.; Lima, M.; Curi, R.; Lima, T.; Moraes, M.; Costa-Lotufo, L. Life Sci. 2006, 78, 2409-2417.
[7] Chang, L.C.; Gerhuser, C.; Song, L.; Farnsworth, N.R.; Pezzuto, J.M.; Kinghorn, A.D. J. Nat. Prod. 1997, 60, 869-873.
[8] Bail, J.C.; Champavier, Y.; Chulia, A.J.; Habrioux, G. Life Sci. 2000, 66, 1281-1291.
[9] Yutaka, K. Jpn. Kokai Tokkyo koho. 1988, 16-18.
[10] Jung, H.J.; Kang, S.S.; Hyun, S.K.; Choi, J.S. Arch. Pharm. Res. 2005, 28, 534-540.
[11] Xu, M.J.; Cui, J.R.; Fu, H.Z.; Proksch, P.; Lin, W.; Li, M. Planta Med. 2005, 71, 944-948.
[12] Ding, G.J.; Fischer, P.A.; Boltz, R.C.; Schmidt, J.A.; Colaianne, J.J.; Gough, A.; Rubin, R.A.; Miller, D.K. J. Biol. Chem. 1998, 273, 28897-28905.
[13] Ghosh, R.N.; Grove, L.; Lapets, O. Assay Drug Dev. Technol. 2004, 2, 473-481.
[14] Um, J.H.; Kang, C.D.; Lee, B.G.; Kim, D.W.; Chung, B.S.; Kim, S.H. Oncogene. 2001, 20, 6048-6056.
[15] Kundu, J.; Surh, Y. Cancer Lett. 2008, 269, 243-261.
[16] Mayo, M.W.; Baldwin, A.S. Biochim. Biophys. Acta. 2000, 1470, M55-M62.
[17] Awale, S.; Li, F.; Onozuka, H.; Esumi, H.; Tezuka, Y.; Kadot, S. Bioorg. Med. Chem. 2008, 16, 181-189.
[18] Li, F.; Awale, S.; Tezuka, Y.; Kadota, S. Bioorg. Med. Chem. 2008, 16, 5434-5440.
[19] Falcão, M.J.; Pouliquem, Y.B.; Lima, M.A.; Gramosa, N.V.; Costa-Lotufo, L.; Militão, G.C.; Pessoa, C.; Moraes, M.O.; Silveira, E.R. J. Nat. Prod. 2005, 68, 423-426.
[20] Wei, S.; Li, M.; Tang, S.; Sun, W.; Xu, B.; Cui, J.; Lin, W. Cancer Lett. 2008, 262, 114-122.
[21] Zhu, Z.; Tananka, S.; Horigome, H.; Hirano, T.; Oka, K. Biol. Pharm. Bull. 2002, 25, 37-41.
[22] Gourlay, C.W.; Ayscough, K.R. Biochem. Soc. Trans. 2005, 33, 1260-1264.

Cytotoxic and pro-apoptotic activities of medicarpin from Canavalia maritima
(Aubl.) via the suppression of NF-κB activation in HeLa cells

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Fan Wang, Ruili Li, Wenjun Wang, Xiaoyan Zhou, Meiyou Liu, Jinyi Zhao, Aidong Wen, Jingwen Wang, Yanyan Jia. α-Boswellic acid ameliorates acute kidney injury by inhibiting the TLR4-mediated inflammatory pathway [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 539-550.
[2]	Kaixiang Deng, Jingzhou Peng, Meiquan Zhang, Huijuan Lin, Xiaohua Wang, Daoxing He, Junming Zhu, Mingguang Chen, Jin Huang. Oyster peptide ameliorates hepatic fibrosis through the NF-κB/iNOS signaling pathway [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(6): 435-445.
[3]	Limei Yang, Liman Wang, Xuhui Huang, Jie Zhuang. Warfarin affects the proliferation and apoptosis of lung cancer cells by regulating the Gas6/Axl/PI3K/Akt/NF-κB pathway [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 190-199.
[4]	Zhaojing Wang, Qingxia Xu, Jing Xu, Wei Xu, Xiuwei Yang. Anti-oxidative and anti-neuroinflammatory effects of corylin in H2O2-induced HT22 cells and LPS-induced BV2 cells by activating Nrf2/HO-1 and inhibiting NF-κB pathways [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 85-100.
[5]	Peijie Chen, Yuntian Zhang. PTP1B restrains the apoptosis of activated hepatic stellate cells (HSCs) induced by TRAIL during the resolution of liver fibrosis [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 867-880.
[6]	Wuyinxiao Zheng, Haiping Li, Laichun Luo, Chunling Hu, Pengtao You. PI3K/AKT/mTOR pathway inhibition and miR-210-mediated suppression of Atg7 promote autophagy in TOPC-induced apoptosis of H1975 cells [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 881-892.
[7]	Neha Dangi, Shikha Sharma. Cancer chemotherapy with novel bioactive natural products [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(8): 589-607.
[8]	Chanjuan Zhang, Likun Hu, He Zhang, Xinyi Qi, Jian Huang, Dong Liu. 2-Hydroxycircumdatin C inhibits LPS-induced BV2 cells inflammatory response via down-regulation of TLR4-mediated NF-κB/MAPK and JAK2/STAT3 pathways [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(4): 239-249.
[9]	Ziyi Wang, Xiaoyan Liu, Yuanjun Zhu, Ye Liu, Pingping Zhang, Yinye Wang. The protective effect of W026B on global cerebral ischemia/reperfusion injury model in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(2): 108-116.
[10]	Hongju Liu, Jing Li, Huiyi Xie, Lingling Wang, Zhizhen Zhang, Chong Yan. Anti-inﬂammatory effects of diaporisoindole B in LPS-stimulated RAW 264.7 macrophage cells via MyD88 activated NF-κB and MAPKs pathways [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(8): 675-685.
[11]	Cong Huang, Carolina Oi Lam Ung, Haishaerjiang Wushouer, Ziyue Xu, Yichen Zhang, Xiaodong Guan, Luwen Shi. The impact of the provincial reimbursement scheme on the use of targeted anticancer medications in Zhejiang, China: a controlled interrupted time-series analysis [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(7): 590-597.
[12]	Chunyang Han, Taotao Sun, Guangtai Fan, Yawei Liu, Cuiyan Liu. Protective effects of Polygonatum sibiricum against CCl4-induced acute liver injury in rats through oxidative stress and mitochondrial apoptotic pathways [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(4): 306-318.
[13]	Ying Kang, Chanjuan Zhang, He Zhang, Dong Liu. Secondary metabolites from a deep-sea-derived Aspergillus versicolor F77 [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(1): 42-48.
[14]	Dini Kesuma, Siswandono, Bambang Tri Purwanto, Marcellino Rudyanto. Synthesis and anticancer evaluation of N-benzoyl-N'-phenyltiourea derivatives against human breast cancer cells (T47D) [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(2): 123-129.
[15]	Kexiang Gao, Xiaoyan Liu, Yuanjun Zhu, Ye Liu, Yinye Wang. The influence of B55γ on the neuroprotective effect of W026B in t-MCAO mice [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 711-718.